Vega CR

Language: Spanish
References: 20
Page: 348-352
PDF size: 501.12 Kb.

ABSTRACT

Physical exercise avoids cardiovascular diseases but when it is intense, it must have correct planning and dosage and, if possible, a previous ergometric test and a guidance specialist could be very useful; because it can also cause cardiovascular events in high performance athletes, among other things, for not complying with a well-defined schedule with a scientific base. The most feared complication is sudden cardiac death, usually due to malignant arrhythmias and ischemic heart disease. Here is presented the case of a 34-year-old high-performance athlete, in the detraining phase and without cardiovascular risk factors or other history of interest, who suffered an extensive acute myocardial infarction, with post-infarction angina, due to a stricture suboclusive of the proximal left anterior descending artery. A rescue angioplasty was performed, with implantation of a drug-eluting stent and the patient evolved favorably.

REFERENCES

1. Yáñez F. Evaluación médica previa a la práctica deportiva para deportistas aficionados y de nivel competitivo. Rev Méd Clín Las Condes. 2012;23(3): 236-43.

2. Zamora Castro R, Frómeta Moreira N. El deportis-ta de alto rendimiento: apuntes para pensar en su desentrenamiento. Lect Educ Fís Deportes (B. Ai-res) [Internet]. 2014 [citado 12 Feb 2019];19(191). Disponible en: https://www.efdeportes.com/efd191/el-deportista-de-alto-rendimiento-su-desentrenamiento.htm

3. Naylor LH, George K, O'Driscoll G, Green DJ. The athlete's heart: a contemporary appraisal of the 'Morganroth hypothesis'. Sports Med. 2008;38(1): 69-90.

4. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, et al. Recommendations for in-terpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31(2):243-59.

5. Uberoi A, Stein R, Perez MV, Freeman J, Wheeler M, Dewey F, et al. Interpretation of the electrocar-diogram of young athletes. Circulation. 2011; 124(6):746-57.

6. Pelliccia A, Maron BJ, Culasso F, Di Paolo FM, Spataro A, Biffi A, et al. Clinical significance of ab-normal electrocardiographic patterns in trained athletes. Circulation. 2000;102(3):278-84.

7. Bille K, Figueiras D, Schamasch P, Kappenberger L, Brenner JI, Meijboom FJ, et al. Sudden cardiac death in athletes: the Lausanne Recommenda-tions. Eur J Cardiovasc Prev Rehabil. 2006;13(6): 859-75.

8. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mue-ller FO. Sudden deaths in young competitive ath-letes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119(8):1085-92.

9. Yañez F. Síndrome corazón de atleta: historia, manifestaciones morfológicas e implicancias clí-nicas. Rev Chil Cardiol. 2012;31(3):215-25.

10. Landry CH, Allan KS, Connelly KA, Cunningham K, Morrison LJ, Dorian P; et al. Sudden cardiac arrest during participation in competitive sports. N Engl J Med. 2017;377(20):1943-53.

11. Wasfy MM, Hutter AM, Weiner RB. Sudden Car-diac Death in Athletes. Methodist Debakey Cardi-ovasc J. 2016;12(2):76-80.

12. Pelliccia A, Adami PE, Quattrini F, Squeo MR, Ca-selli S, Verdile L, et al. Are Olympic athletes free from cardiovascular diseases? Systematic investi-gation in 2352 participants from Athens 2004 to Sochi 2014. Br J Sports Med. 2017;51(4):238-43.

13. Sanagua JO, Acosta GE. Screening Cardiovascular en el deportista de alto rendimiento que llega a nuestro consultorio: Metodología de estudio, exá-menes complementarios [Internet]. 2do Congreso Virtual de Cardiología [citado17 Feb 2019]; Argen- tina: 2001. Disponible en: http://www.fac.org.ar/scvc/llave/PDF/sanaguae.PDF

14. Shah N, Kelly AM, Cox N, Wong C, Soon K. Myo-cardial infarction in the "Young": Risk factors, presentation, management and prognosis. Heart Lung Circ. 2016;25(10):955-60.

15. Álvarez Cortés JT, Bello Hernández V, Pérez He-chavarría GA, Antomarchi Duany O, Bolívar Ca-rrión ME. Factores de riesgo coronarios asocia-dos al infarto agudo del miocardio en el adulto mayor. MEDISAN [Internet]. 2013 [citado 20 Feb 2019];17(1):54-60. Disponible en: http://scielo.sld.cu/pdf/san/v17n1/san08113.pdf

16. Schindler TH. Myocardial blood flow: Putting it into clinical perspective. J Nucl Cardiol. 2016; 23(5):1056-71.

17. Ibanez B, James S, Agewall S, Antunes MJ, Bucci-arelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarc-tion in patients presenting with ST-segment eleva-tion: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77.

18. Moreno-Martínez FL, Chávez-González E, Moreno-Valdés MT, Oroz Moreno R. Promoción de salud para reducir el retraso en buscar atención médi-ca de los pacientes con síndrome coronario agu-do. Rev Esp Cardiol. 2016;69(7):713.

19. Rivero F, Bastante T, Cuesta J, Benedicto A, Sa-lamanca J, Restrepo JA, et al. Factores asociados al retraso en la demanda de atención médica en pacientes con síndrome coronario agudo con elevación del segmento ST. Rev Esp Cardiol. 2016;69(3):279-85.

20. Reimer KA, Jennings RB. The “wavefront phe-nomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40(6): 633-44.